Business
Third member of FDA advisory panel resigns over Alzheimer’s drug approval – NBC News
A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s…
A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…
Continue Reading
-
Noosa News23 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General23 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
Business22 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?